Profile
Paul Schaffer currently works at Telix Pharmaceuticals Ltd., as Chief Technology Officer from 2025.
Dr. Schaffer also formerly worked at Centre For Probe Development & Commercialization, as Director from 2018 to 2021 and ARTMS, Inc., as Chief Technology Officer from 2018 to 2025.
Paul Schaffer active positions
| Companies | Position | Start |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | 06/04/2025 |
Former positions of Paul Schaffer
| Companies | Position | End |
|---|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 27/03/2018 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Director/Board Member | 16/06/2021 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
- Stock Market
- Insiders
- Paul Schaffer
















